Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans

Experimental and Clinical Psychopharmacology

Volumn 6, Issue 1, 1998, Pages 32-44

  Rush, Craig R ^a   Kollins, Scott H ^a   Pazzaglia, Peggy J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; METHYLPHENIDATE; PLACEBO; TRIAZOLAM;

ADULT; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TRAINING;

ADULT; AFFECT; BLOOD PRESSURE; BUPROPION; DEXTROAMPHETAMINE; DISCRIMINATION (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; FEMALE; GABA MODULATORS; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; TRIAZOLAM;

EID: 0031889005     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.6.1.32     Document Type: Article

References (46)

1. Abreu, M. E., & Griffiths, R. R. (1996). Drug tasting may confound human drug discrimination studies. Psychopharmacology, 125, 255-257.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Baron, A., & Galizio, M. (1983). Instructional control of human operant behavior. Psychological Record, 33, 495-520.
4. Bergman, J., Madras, B., Johnson, S. E., & Spealman, R. D. (1989). Effects of cocaine and related drugs in nonhuman primates: III. Self-administration by squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 251, 150-155.
5. Chait, L. D. (1994). Reinforcing and subjective effects of methylphenidate in humans. Behavioural Pharmacology, 5, 281-288.
6. Chait, L. D., & Johanson, C. E. (1988). Discriminative stimulus effects of caffeine and benzphetamine in amphetamine trained volunteers. Psychopharmacology, 96, 302-308.
7. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1984). An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology, 82, 272-274.
8. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1985). The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology, 86, 307-312.
9. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1986a). The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology, 89, 301-306.
10. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1986b). The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans. Pharmacology Biochemistry and Behavior, 24, 301-306.
11. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1989). Individual differences in the discriminative stimulus effects of d-amphetamine in humans. Drug Development and Research, 16, 451-460.
12. Davidson, J. (1989). Seizures and bupropion: A review. Journal of Clinical Psychiatry, 50, 256-261.
13. de la Garza, R., & Johanson, C. E. (1987). The discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in Rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 243, 955-962.
14. Drug Abuse Warning Network (DAWN). (1991). Annual medical examiner data 1990: Data from the drug abuse warning network (DHHS Publication No. ADM 91-1840). Rockville, MD: National Institute on Drug Abuse.
15. Drug Enforcement Administration. (1995). Press release [On line]. Available World Wide Web: Methylphenidate http://www.usdo-j.gov/dea/pressrel/pr951020.htm.
16. Evans, S. M., & Johanson, C. E. (1987). Amphetamine-like effects of anorectics and related compounds in pigeons. Journal of Pharmacology and Experimental Therapeutics, 241, 817-825.
17. Griffith, J. D., Carranza, J., Griffith, C., & Miller, L. L. (1983). Bupropion: Clinical assay for amphetamine-like abuse potential. Journal of Clinical Psychiatry, 44, 206-208.
18. Heikkila, R. E., & Manzino, L. (1984). Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. European Journal of Pharmacology, 103, 241-248.
19. Heishman, S. J., & Henningfield, J. E. (1991). Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology, 103, 436-442.
20. Hoffman, B. B., & Lefkowitz, R. J. (1990). Catecholamines and sympathomimetic drugs. In A. G. Gilman, T. W. Rall, A. S. Nies, & P. Taylor (Eds.), Goodman and Gilman's the pharmacological basis of therapeutics (8th ed., pp. 187-220). New York: Pergamon Press.
21. Holmes, V. F. (1995). Medical use of psychostimulants: An overview. International Journal of Psychiatry in Medicine, 25, 1-19.
22. Jasinski, D. R. (1977). Assessment of the abuse potentially of morphine-like drugs (methods used in man). In W. R. Martin (Ed.), Drug Addiction I (pp. 197-258). New York: Springer-Verlag.
23. Javitch, J. A., Blaustein, R. O., & Snyder, S. H. (1984). [3H] Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Molecular Pharmacology, 26, 35-44.
24. Johanson, C. E., & Schuster, C. R. (1975). A choice procedure for drug reinforcers: Cocaine and methylphenidate in Rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 193, 676-688.
25. Johnston, J. A., Lineberry, C. G., Ascher, J. A., Davidson, J., Khayrallah, M. A., Feighner, J. P., & Stark, P. (1991). A 102-center prospective study of seizure in association with bupropion. Journal of Clinical Psychopharmacology, 52, 450-456.
26. Kamien, J. B., Bickel, W. K., Hughes, J. R., Higgins, S. T., & Smith, B. J. (1993). Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology, 111, 259-270.
27. Kamien, J. B., & Woolverton, W. L. (1989). A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in Rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 248, 938-946.
28. Kollins, S. H., Daleiden, E., Chorpita, B. F., & Sturges, J. W. (1997). A survey of medication use in school-aged children as reported by principals. Manuscript submitted for publication.
29. Lamb, R. J., & Henningfield, J. E. (1994). Human d-amphetamine drug discrimination: Methamphetamine and hydromorphone. Journal of the Experimental Analysis of Behavior, 61, 169-180.
30. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man [Monograph]. Clinical Pharmacology and Therapeutics, 12(2, Part 1), 245-258.
31. McLeod, D. R., Griffiths, R. R., Bigelow, G. E., & Yingling, J. E. (1982). An automated version of the digit symbol substitution test (DSST). Behavioral Research Methods and Instrumentation, 14, 463-466.
32. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Profile of Mood States [Manual]. San Diego, CA: Educational and Industrial Testing Services.
33. Miller, L., & Griffith, J. D. (1983). A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology, 80, 199-205.
34. Peck, A. W., Bye, C. E., Clubley, M., Henson, T., & Riddington, C. (1979). A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects. British Journal of Clinical Pharmacology, 7, 469-418.
35. Preston, K. L., & Bigelow, G. E. (1994). Drug discrimination assessment of agonist-antagonist opioids in humans: A three-choice saline-hydromorphone-butorphanol procedure. Journal of Pharmacology and Experimental Therapeutics, 271, 48-60.
36. Preston, K. L., Bigelow, G. E., Bickel, W. K., & Liebson, I. A. (1987). Three-choice drug discrimination in opioid-dependent humans: Hydromorphone, naloxone and saline. Journal of Pharmacology and Experimental Therapeutics, 243, 1002-1009.
37. Preston, K. L., Bigelow, G. E., Bickel, W. K., & Liebson, I. A. (1989). Drug discrimination in human postaddicts: Agonist-antagonist opioids. Journal of Pharmacology and Experimental Therapeutics, 250, 184-196.
38. Preston, K. L., Bigelow, G. E., & Liebson, I. A. (1990). Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacology Biochemistry and Behavior, 37, 511-522.
39. Rosenstein, D. L., Nelson, C., & Jacobs, S. C. (1993). Seizures associated with antidepressants: A review. Journal of Clinical Psychiatry, 54, 289-299.
40. Rush, C. R., Critchfield, T. S., Troisi, J. R. II, & Griffiths, R. R. (1995). Discriminative stimulus effects of diazepam and buspirone in normal volunteers. Journal of the Experimental Analysis of Behavior, 63, 277-294.
41. Rush, C. R., Madakasira, S., & Goldman, N. H. (1996). Acute behavioral effects of estazolam and triazolam in non-drug abusing volunteers. Experimental and Clinical Psychopharmacology, 4, 300-307.
42. Rush, C. R., Madakasira, S., Goldman, N. H., Woolverton, W. L., & Rowlett, J. K. (1997). Discriminative-stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. Journal of Pharmacology and Experimental Therapeutics, 280, 174-188.
43. Rush, C. R., Madakasira, S., Hayes, C. A., Johnson, C. A., Goldman, N. H., & Pazzaglia, P. J. (1997). Trazodone and triazolam: Acute subject-rated and performance-impairing effects in healthy volunteers. Psychopharmacology, 131, 9-18.
44. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256-2258.
45. Wilens, T. E., Biederman, J., Spencer, T. J., & Prince, J. (1995). Pharmacotherapy of adult attention deficit/hyperactivity disorder: A review. Journal of Clinical Psychopharmacology, 15, 270-279.
46. Wilson, M. C., Hitomi, M., & Schuster, C. R. (1971). Psychomotor stimulant self-administration as a function of dosage per injection in the Rhesus monkey. Psychopharmacology, 22, 271-281.